Why Diversity, Equity and Inclusion Are Vital to the Psychedelic Industry
Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should “harness the power of diversity.”
Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should “harness the power of diversity.”
Another clinic gets approval to conduct MDMA research, and new psychedelic research facilities open in Australia and the U.S., plus two game-changing psilocybin patents.
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.